Related Experiment Videos

Stabilization of beta-catenin by genetic defects in melanoma cell lines

B Rubinfeld1, P Robbins, M El-Gamil

  • 1Onyx Pharmaceuticals, 3031 Research Drive, Richmond, CA 94806, USA.

Science (New York, N.Y.)
|March 21, 1997
PubMed

Insights

Genetic defects stabilize beta-catenin, a key protein in signal transduction. This stabilization, linked to mutations or altered APC protein, may drive melanoma progression in affected human melanoma cell lines.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Beta-catenin is crucial for signal transduction, linking to Lef and Tcf transcription factors.
  • Aberrant beta-catenin signaling is implicated in various cancers, including melanoma.

Purpose of the Study:

  • To investigate the role of beta-catenin stabilization in human melanoma cell lines.
  • To identify the genetic alterations leading to beta-catenin up-regulation in melanoma.

Main Methods:

  • Analysis of beta-catenin levels in 26 human melanoma cell lines.
  • Sequencing of the beta-catenin gene (CTNNB1) and assessment of adenomatous polyposis coli tumor suppressor protein (APC) status.
  • Functional studies involving ectopic expression of wild-type APC.

Main Results:

  • Abnormally high beta-catenin levels were found in 7 out of 26 melanoma cell lines.
  • Mutations in CTNNB1 (splicing or missense) causing stabilization were identified in 6 lines.
  • Altered or missing APC was observed in 2 lines; wild-type APC expression reduced beta-catenin.
  • Stabilized beta-catenin formed constitutive complexes with Lef-1.

Conclusions:

  • Genetic defects leading to beta-catenin up-regulation, including CTNNB1 mutations and APC alterations, are present in a subset of human melanomas.
  • These genetic alterations result in stabilized beta-catenin and constitutive signaling, suggesting a role in melanoma progression.

Related Concept Videos